Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: Analysis of prevalence and incidence screening

BMJ (Online)

Volumn 341, Issue 7780, 2010, Pages 979-

  Steele, R J C ^a,b   Kostourou, I ^a,b   McClements, P ^c   Watling, C ^c   Libby, G ^b   Weller, D ^d   Mackenzie, James ^d   Brewster, D H ^c   Black, R ^c   Carey, F A ^a   Fraser, C ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b King's Cross Hospital   (United Kingdom)

^c Information Services   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HUMAN; MALE; OCCULT BLOOD; PRIORITY JOURNAL;

AGED; APPOINTMENTS AND SCHEDULES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; REMINDER SYSTEMS;

EID: 78049504461     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c5531     Document Type: Article

References (19)

1. Duffy SW, Gabe R. What should the detection rates of cancers be in breast screening programmes? Br J Cancer 2005;92:597-600.
2. Mandel JS, Bond JH, Church JR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl JMed 1993;328;1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348;1472-7.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348;1467-71. (Pubitemid 26400241)
5. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008;95:1029-36.
6. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by faecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80.
7. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the faecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541-9.
8. Steele RJC, Parker R, Patnick J, Warner J, Fraser C, Mowat NA, et al. A demonstration pilot for colorectal cancer in the UK: a new concept in the introduction of health care strategies. J Med Screen 2001;8:197-202.
9. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133-5.
10. Steele RJC, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009;58:530-5.
11. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002;9:153-8. (Pubitemid 36135340)
12. Otten JD, van Dijick JA, Peer PG, Straatman H, Verbeek AL, Mravunac M, et al. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 1996;50:353-8.
13. Blanks RG, Moss SM, Patnick J. Results from the UK NHS breast screening programme 1994-1999. J Med Screen 2000;7:195-8.
14. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357-67.
15. Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT based colorectal screening programme. J Med Screen 2010;17:68-74.
16. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
17. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
18. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: a randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
19. Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, et al. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer 2010;46:2059-66.